{{org_field_logo}}

{{org_field_name}}

Registration Number: {{org_field_registration_no}}


PRN Medication Management Policy

1. Purpose and Scope

The purpose of this PRN Medication Management Policy is to provide clear guidelines for the safe, effective, and person-centred management of “as-needed” (PRN) medication within {{org_field_name}}. This policy ensures that PRN medications are administered appropriately, recorded accurately, and monitored effectively to promote the health and well-being of service users.

This policy applies to all staff members involved in the administration, management, and monitoring of PRN medication, including care workers, supervisors, and management. It covers all aspects of PRN medication handling, from prescription to administration and documentation.

2. Policy Statement

{{org_field_name}} is committed to:

We believe that the appropriate use of PRN medication enhances the quality of life for service users while safeguarding their health and well-being.

3. Legal and Regulatory Framework

This policy is implemented in accordance with the following current legislation, regulations and national guidance:

PRN medicines must only be supported or administered where the responsibility for medicines support has been assessed, agreed and clearly documented in the service user’s care plan.

4. Definitions

5. PRN Medication Assessment and Planning

Every service user who requires staff support with PRN medication must have clear, person-centred written guidance available to staff.

The PRN medication plan must be consistent with the prescription, dispensing label, care plan and current medicines record.

For each PRN medicine, the plan must specify, as applicable:

Where a variable dose has been prescribed, staff must have sufficiently clear written directions to determine the appropriate dose safely.

If the directions are unclear, contradictory or insufficient, staff must not guess. Advice must be obtained from the prescriber, pharmacist or other appropriate healthcare professional.

PRN Medication Outside Scheduled Care Visits

For domiciliary care, the care plan must state how PRN medication needs will be managed outside scheduled care-worker visits.

Where family members or other carers may provide support, the plan must identify:

Staff must have access to the current PRN plan whenever they are expected to make a decision about offering or administering PRN medication.

PRN Medicines for Distress, Agitation or Behaviour

Where PRN psychotropic medication is prescribed for distress, agitation or behaviour:

Where relevant, practice should reflect the principles of STOMP for people with a learning disability and autistic people.

6. Consent and Capacity

6.1. Consent

A person with capacity must be involved in decisions concerning their PRN medication and has the right to accept or decline it.

Staff must:

An unwise decision or refusal does not by itself mean that the person lacks capacity.

6.2. Mental Capacity

Where there is reasonable doubt about the person’s capacity to make the particular medication decision, {{org_field_name}} will follow the Mental Capacity Act 2005.

Capacity must be:

All practicable steps must first be taken to support the person to make their own decision.

Where the person lacks capacity, a lawful best-interests decision must be made by the appropriate decision-maker.

Family members, carers and advocates may be consulted where appropriate, but they do not automatically have legal authority to consent to medication on the person’s behalf.

Where a health and welfare attorney or Court-appointed deputy has relevant authority, that authority will be checked and respected within its lawful limits.

Capacity assessments and best-interests decisions must be clearly documented.

6.3. Covert PRN Administration

PRN medication must not be concealed in food, drink or another substance merely because a person refuses it.

Covert administration may only occur where:

The covert plan must record:

Covert administration must be recorded clearly on the medicines administration record.

Where capacity fluctuates, a covert administration plan must only be used at a time when the person actually lacks capacity for the relevant decision.

Covert administration arrangements must be reviewed regularly.

7. Safe Administration of PRN Medication

PRN medication must only be administered by staff who are authorised, appropriately trained and assessed as competent.

Before administration, staff must:

  1. Check the person’s current care plan and PRN medication plan.
  2. Check the prescription, dispensing label and MAR or electronic medicines record.
  3. Confirm the service user’s identity.
  4. Confirm the indication for the PRN medicine.
  5. Assess whether the person’s current symptoms meet the documented PRN criteria.
  6. Check whether the person has already received or taken the medicine.
  7. Check the time of the previous dose.
  8. Confirm that the minimum interval between doses has passed.
  9. Check that administration will not exceed the prescribed maximum dose within the relevant period.
  10. Ask whether the person is ready and willing to take the medicine.

Six Rights of Medicines Administration

Staff must apply the six rights:

Accurate documentation remains essential but is not the sixth right.

Following Administration

Staff must:

Where the PRN medicine is being required more frequently than expected, appears ineffective, causes adverse effects or is being used in circumstances not covered by the existing plan, staff must escalate this to the appropriate healthcare professional and management.

Staff must not independently change:

8. Documentation and Record Keeping

Accurate documentation is essential for safe PRN medication management. Staff must:

The PRN record includes:

9. Monitoring and Review

PRN medication use is regularly monitored to ensure effectiveness and safety. This includes:

Key considerations during review include:

If concerns arise, the care team consults the prescribing healthcare professional for reassessment.

10. Staff Training and Competency

All staff administering PRN medication must:

Training covers:

11. Storage and Disposal of PRN Medication

PRN medicines belong to the service user and will normally be stored in the person’s own home.

Storage arrangements must reflect:

Storage

PRN medicines should normally:

PRN medicines do not automatically need to:

Secure storage will be used where an individual risk assessment identifies that this is necessary.

The care plan must record any agreed storage arrangements.

Controlled Drugs

Where a PRN medicine is a controlled drug:

In a person’s own home there is no automatic legal requirement:

Where the person’s circumstances create a risk of theft, diversion, misuse, accidental access or harm, appropriate secure-storage arrangements will be put in place.

Disposal

Responsibility for returning or disposing of unwanted or expired PRN medicines must be agreed with the person and/or appropriate representative and recorded in the care plan.

Where {{org_field_name}} accepts responsibility:

Staff must not dispose of medicines in ordinary household waste, sinks or toilets.

12. Handling Refusals and Errors

Where a person with capacity declines PRN medication:

Medication Errors and Near Misses

Any PRN medication error or near miss must be reported promptly through {{org_field_name}}’s medicines and incident-reporting arrangements.

Immediate priorities are to:

  1. Protect the service user from further harm.
  2. Obtain appropriate clinical advice where necessary.
  3. Contact emergency services where there is an immediate serious risk.
  4. Inform the appropriate manager.
  5. Record what occurred accurately.
  6. Complete the appropriate MAR entry without falsifying or obscuring the original record.
  7. Complete an incident report.
  8. Preserve relevant evidence.
  9. Review the incident and identify learning.

Examples include:

Safeguarding

Medication incidents must also be considered under safeguarding procedures.

A medicines-related safeguarding concern may include:

Where appropriate, the concern will be referred to the local authority safeguarding team in accordance with {{org_field_name}}’s Safeguarding Adults Policy.

Controlled-Drug Incidents

Loss, theft, diversion, discrepancy or other significant incident involving controlled drugs will be escalated in accordance with applicable controlled-drug requirements.

Where appropriate this may include liaison with:

CQC Notifications

A PRN medication error does not automatically require a CQC statutory notification.

The Registered Manager must assess whether the incident has resulted in a separately notifiable event, including:

Where a statutory notification is required, it must be submitted within the legally required timescale and the medicines error should be identified as a known or possible cause or contributory factor.

Duty of Candour

{{org_field_name}} will act openly and transparently where a medicines-related incident affects a person.

The formal Regulation 20 Duty of Candour procedure will be followed where the incident meets the statutory definition of a notifiable safety incident.

Where the formal threshold is not met, the organisation will nevertheless communicate appropriately with the service user about what happened and any action required.

Learning

All medication errors and relevant near misses will be reviewed to identify:

Corrective and preventative actions will be documented and monitored.

13. Communication and Collaboration

Effective communication ensures safe PRN medication management. This includes:

14. Audit and Quality Assurance

We conduct regular audits to ensure adherence to this policy, including:

Audit findings inform continuous improvement, ensuring safe, effective PRN medication management.

{{org_field_name}} is committed to the safe, person-centred management of PRN medication. By following this comprehensive policy, we ensure that service users receive appropriate, effective medication while safeguarding their health and well-being. All staff must adhere to this policy and promote best practices in PRN medication management.

15. Policy Review and Updates

This policy will be reviewed at least annually, or sooner where necessary, to ensure that PRN medication arrangements remain safe, person-centred and consistent with current legislation, CQC requirements and NICE guidance.

An earlier review will take place where:

The Registered Manager will ensure that the review considers:

Where weaknesses are identified, {{org_field_name}} will:

Material amendments will be documented, approved and communicated to relevant staff.

Learning from medication incidents, near misses, complaints, safeguarding concerns and audits will be used to continuously improve PRN medication safety.


Responsible Person: {{org_field_registered_manager_first_name}} {{org_field_registered_manager_last_name}}
Reviewed on:
{{last_update_date}}
Next Review Date:
{{next_review_date}}
Copyright © {{current_year}} – {{org_field_name}}. All rights reserved.

Leave a Reply

Your email address will not be published. Required fields are marked *